Monitoring vital signs of patients at home
Continuous Monitoring With Real-time Transmission of Vital Signs to Healthcare Professionals From Patients at Home
Bispebjerg Hospital · NCT06077851
This study is testing whether using wireless devices to monitor vital signs at home can help keep high-risk patients out of the hospital and reduce the number of times they need to be readmitted.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bispebjerg Hospital (other) |
| Locations | 1 site (Copenhagen, NV) |
| Trial ID | NCT06077851 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of wireless, continuous monitoring of vital signs in patients at home, focusing on the frequency of alarms triggered by abnormal parameters and their implications for hospital readmission or serious adverse events within 30 days. It aims to address the challenges of acute hospital admissions and the common occurrence of readmissions among patients with chronic conditions. By utilizing recent advancements in technology, the study seeks to provide real-time analytics of vital signs for high-risk patients, potentially alleviating hospital overcrowding.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have been admitted for acute medical conditions and are scheduled for discharge to their homes.
Not a fit: Patients receiving palliative treatment or those with certain chronic conditions and abnormal vital parameters may not benefit from this monitoring.
Why it matters
Potential benefit: If successful, this approach could significantly reduce hospital readmissions and improve patient outcomes by allowing for timely interventions at home.
How similar studies have performed: While continuous monitoring in hospitals has shown promise, this specific approach for home monitoring is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Adult patients (≥18 years) admitted (with at least one night stay) with an acute medical disease and scheduled for discharge to their own homes Adult patients (≥18 years) who have contacted the EMS and, after assessment by paramedic personnel, not deemed sick enough for immediate hospital admission. Exclusion Criteria: Patients placed on palliative treatment. Acceptable chronically abnormal vital parameters of SpO2\<88%, MAP\<70, RR\>24, or HR\>110. Allergy to plaster, plastic, or silicone. A pacemaker or Implantable Cardioverter Defibrillator (ICD) device. If the patient was deemed not able to open the front door when visited by the investigator. Inability to give informed consent.
Where this trial is running
Copenhagen, NV
- Bispebjerg Hospital — Copenhagen, NV, Denmark (RECRUITING)
Study contacts
- Principal investigator: Emilie Sigvardt, MD — Bispebjerg Hospital
- Study coordinator: Emilie Sigvardt, MD
- Email: emilie.sigvardt@regionh.dk
- Phone: 28254123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Vital Sign Monitoring, Clinical Deterioration, Hospital At Home